Extracellular matrix stiffness regulates degradation of MST2 via SCF βTrCP
The Hippo pathway plays central roles in relaying mechanical signals during development and tumorigenesis, but how the proteostasis of the Hippo kinase MST2 is regulated remains unknown. Here, we found that chemical inhibition of proteasomal proteolysis resulted in increased levels of MST2 in human...
Saved in:
Published in | Biochimica et biophysica acta. General subjects Vol. 1866; no. 12; p. 130238 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.12.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The Hippo pathway plays central roles in relaying mechanical signals during development and tumorigenesis, but how the proteostasis of the Hippo kinase MST2 is regulated remains unknown. Here, we found that chemical inhibition of proteasomal proteolysis resulted in increased levels of MST2 in human breast epithelial cells. MST2 binds SCFβTrCP E3 ubiquitin ligase and silencing βTrCP resulted in MST2 accumulation. Site-directed mutagenesis combined with computational molecular dynamics studies revealed that βTrCP binds MST2 via a non-canonical degradation motif. Additionally, stiffer extracellular matrix, as well as hyperactivation of integrins resulted in enhanced MST2 degradation mediated by integrin-linked kinase (ILK) and actomyosin stress fibers. Our study uncovers the underlying biochemical mechanisms controlling MST2 degradation and underscores how alterations in the microenvironment rigidity regulate the proteostasis of a central Hippo pathway component.
•Chemical inhibition of the proteasome results in increased levels of MST2 in human breast epithelial cells.•SCFβTrCP E3-ligase binds MST2 and silencing βTrCP results in MST2 accumulation.•βTrCP binds MST2 via a non-canonical degradation motif.•Stiffer ECM and hyperactivation of integrins promote enhanced MST2 degradation mediated by ILK and actomyosin contraction. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Author contribution APZPF planned, performed, analyzed most experiments and co-wrote the manuscript. AMRS performed all the RT-qPCRs and immunoblots in Supplementary Fig. 4. PRF manufactured all hydrogels. ACM generated cDNA constructs and performed the protein stability assay. MCSB cultured the breast cell lines used in the experiments shown in Fig. 2A. CV supervised the ubiquitylation assay and edited the manuscript. HVRF and PSLO performed the molecular dynamics studies. MP co-supervised part of the study and edited the mansucript. AB-C planned experiments, analyzed data, supervised the study and wrote the manuscript. |
ISSN: | 0304-4165 1872-8006 1872-8006 |
DOI: | 10.1016/j.bbagen.2022.130238 |